ACTISINE Trademark

Trademark Overview


On Tuesday, August 13, 2024, a trademark application was filed for ACTISINE with the United States Patent and Trademark Office. The USPTO has given the ACTISINE trademark a serial number of 98695400. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, August 13, 2024. This trademark is owned by Bellus Medical, LLC. The ACTISINE trademark is filed in the Medical Instrument Products category with the following description:

Micro-needling device designed to address acne scars, hyperpigmentation, stretch marks, skin texture as well as, fine lines and wrinkles by stimulating the skin's natural ability to produce new collagen formation creating healthier skin
actisine

General Information


Serial Number98695400
Word MarkACTISINE
Filing DateTuesday, August 13, 2024
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateTuesday, August 13, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesMicro-needling device designed to address acne scars, hyperpigmentation, stretch marks, skin texture as well as, fine lines and wrinkles by stimulating the skin's natural ability to produce new collagen formation creating healthier skin

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateTuesday, August 13, 2024
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBellus Medical, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressDallas, TX 75244

Trademark Events


Event DateEvent Description
Tuesday, August 13, 2024NEW APPLICATION ENTERED